274 related articles for article (PubMed ID: 33008384)
1. Pharmacy preparedness and response for the prevention and control of coronavirus disease (COVID-19) in Aksum, Ethiopia; a qualitative exploration.
Kasahun GG; Kahsay GM; Asayehegn AT; Demoz GT; Desta DM; Gebretekle GB
BMC Health Serv Res; 2020 Oct; 20(1):913. PubMed ID: 33008384
[TBL] [Abstract][Full Text] [Related]
2. Providing pharmacy services during the coronavirus pandemic.
Liu S; Luo P; Tang M; Hu Q; Polidoro JP; Sun S; Gong Z
Int J Clin Pharm; 2020 Apr; 42(2):299-304. PubMed ID: 32222911
[TBL] [Abstract][Full Text] [Related]
3. Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists' experiences with preventative measures and sources of information.
Hoti K; Jakupi A; Hetemi D; Raka D; Hughes J; Desselle S
Int J Clin Pharm; 2020 Aug; 42(4):1197-1206. PubMed ID: 32524513
[TBL] [Abstract][Full Text] [Related]
4. How medicines sales staff is responding to presumptive COVID-19 patients attending drug retail outlets: An exploratory qualitative study.
Atif M; Ahmad M; Malik I; Mushtaq I; Ahmad N; Mehjabin ; Babar ZU
Int J Health Plann Manage; 2021 Nov; 36(6):2297-2312. PubMed ID: 34390010
[TBL] [Abstract][Full Text] [Related]
5. The Particularities of Pharmaceutical Care in Improving Public Health Service during the COVID-19 Pandemic.
Ghibu S; Juncan AM; Rus LL; Frum A; Dobrea CM; Chiş AA; Gligor FG; Morgovan C
Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574698
[TBL] [Abstract][Full Text] [Related]
6. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
Aruru M; Truong HA; Clark S
Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
[TBL] [Abstract][Full Text] [Related]
7. Pharmacists' Preparedness to Patients Education at the Time of Pandemic-A Cross-Sectional Study with an Example of SARS-CoV-2 Outbreak in Poland.
Cerbin-Koczorowska M; Waszyk-Nowaczyk M; Przymuszała P
Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32932684
[TBL] [Abstract][Full Text] [Related]
8. Investigation on cognition of COVID-19 and safety during the pandemic among hospital pharmacy staff.
He Y; Li W; Liu D
Eur J Hosp Pharm; 2020 Nov; 27(6):e100. PubMed ID: 32371528
[No Abstract] [Full Text] [Related]
9. Hospital Pharmacy in the multidisciplinary team of COVID inpatient units.
Gil-Navarro MV; Luque-Márquez R
Farm Hosp; 2020 Jun; 44(7):40-42. PubMed ID: 32533669
[TBL] [Abstract][Full Text] [Related]
10. Perspectives of compounding pharmacists on alcohol-based hand sanitizer production and utilization for COVID-19 prevention in Addis Ababa, Ethiopia: A descriptive phenomenology study.
Baye AM; Ababu A; Bayisa R; Abdella M; Diriba E; Wale M; Selam MN
PLoS One; 2021; 16(4):e0250020. PubMed ID: 33914768
[TBL] [Abstract][Full Text] [Related]
11. Provision of clinical pharmacy services during the COVID-19 pandemic: Experiences of pharmacists from 16 European countries.
Paudyal V; Cadogan C; Fialová D; Henman MC; Hazen A; Okuyan B; Lutters M; Stewart D
Res Social Adm Pharm; 2021 Aug; 17(8):1507-1517. PubMed ID: 33288420
[TBL] [Abstract][Full Text] [Related]
12. Global oncology pharmacy response to COVID-19 pandemic: Medication access and safety.
Alexander M; Jupp J; Chazan G; O'Connor S; Chan A
J Oncol Pharm Pract; 2020 Jul; 26(5):1225-1229. PubMed ID: 32408842
[TBL] [Abstract][Full Text] [Related]
13. Community Pharmacists' Contributions to Disease Management During the COVID-19 Pandemic.
Strand MA; Bratberg J; Eukel H; Hardy M; Williams C
Prev Chronic Dis; 2020 Jul; 17():E69. PubMed ID: 32701431
[TBL] [Abstract][Full Text] [Related]
14. Exploring the Pharmaceutical Care of Pharmacists in China During COVID-19-A National Multicenter Qualitative Study.
Wang M; Yin Z; Zhang W; Jia X; Du S; Li J; Zhang X
Front Public Health; 2021; 9():797070. PubMed ID: 35155350
[TBL] [Abstract][Full Text] [Related]
15.
Patterson SM; Cadogan CA; Barry HE; Hughes CM
BMJ Open; 2022 Sep; 12(9):e064549. PubMed ID: 36137632
[TBL] [Abstract][Full Text] [Related]
16. The coping strategies of community pharmacists and pharmaceutical services provided during COVID-19 in Malaysia.
Kua KP; Lee SWH
Int J Clin Pract; 2021 Dec; 75(12):e14992. PubMed ID: 34710264
[TBL] [Abstract][Full Text] [Related]
17. Perceived barriers to the practice of preventive measures for COVID-19 pandemic among health professionals in public health facilities of the Gamo zone, southern Ethiopia: a phenomenological study.
Mersha A; Shibiru S; Girma M; Ayele G; Bante A; Kassa M; Abebe S; Shewangizaw M
BMC Public Health; 2021 Jan; 21(1):199. PubMed ID: 33482790
[TBL] [Abstract][Full Text] [Related]
18. Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service.
Krska J; Mackridge AJ
Public Health; 2014 Apr; 128(4):309-16. PubMed ID: 24713598
[TBL] [Abstract][Full Text] [Related]
19. Chinese pharmacists' rapid response to the COVID-19 outbreak.
Tan SL; Zhang BK; Xu P
Am J Health Syst Pharm; 2020 Jul; 77(14):1096-1097. PubMed ID: 32399549
[No Abstract] [Full Text] [Related]
20. Stopping the Spread of the COVID-19 Pandemic: The Case for Using Pharmacists, Pharmacy Interns, and Pharmacy Technicians as Contact Tracers.
Kostrzewa AB; Slater SJ
Am J Public Health; 2020 Nov; 110(11):1653-1655. PubMed ID: 33026857
[No Abstract] [Full Text] [Related]
[Next] [New Search]